BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32315177)

  • 21. Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.
    Oh AY; Jung YS; Kim J; Lee JH; Cho JH; Chun HY; Park S; Park H; Lim S; Ha NC; Park JS; Park CS; Song GY; Park BJ
    Cancer Res; 2016 Aug; 76(16):4791-804. PubMed ID: 27302160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer.
    Choi JW; Lee JW; Kim JK; Jeon HK; Choi JJ; Kim DG; Kim BG; Nam DH; Kim HJ; Yun SH; Kim S
    J Mol Cell Biol; 2012 Jun; 4(3):164-73. PubMed ID: 22532625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer.
    Ku J; Kim R; Kim D; Kim D; Song S; Lee K; Lee N; Kim M; Yoon SS; Kwon NH; Kim S; Kim Y; Koh Y
    Commun Biol; 2020 Oct; 3(1):630. PubMed ID: 33128014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis.
    Choi JW; Kim DG; Lee AE; Kim HR; Lee JY; Kwon NH; Shin YK; Hwang SK; Chang SH; Cho MH; Choi YL; Kim J; Oh SH; Kim B; Kim SY; Jeon HS; Park JY; Kang HP; Park BJ; Han JM; Kim S
    PLoS Genet; 2011 Mar; 7(3):e1001351. PubMed ID: 21483803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid detection of exon 2-deleted AIMP2 mutation as a potential biomarker for lung cancer by molecular beacons.
    Jo SM; Kim Y; Jeong YS; Hee Oh Y; Park K; Kim HS
    Biosens Bioelectron; 2013 Aug; 46():142-9. PubMed ID: 23537880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor-Suppressive Interaction with Smurf2.
    Kim DG; Lee JY; Lee JH; Cho HY; Kang BS; Jang SY; Kim MH; Guo M; Han JM; Kim SJ; Kim S
    Cancer Res; 2016 Jun; 76(11):3422-36. PubMed ID: 27197155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methionyl-tRNA synthetase and aminoacyl-tRNA synthetases interacting multi-functional protein-lacking exon 2 as potential diagnostic biomarkers for lung cancer.
    Kim T; Lee K; Nahm JH; Kim EY; Lee SH; Chang YS
    Am J Cancer Res; 2021; 11(6):3135-3144. PubMed ID: 34249450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor.
    Hu J; Wang Y; Li Y; Xu L; Cao D; Song S; Damaneh MS; Wang X; Meng T; Chen YL; Shen J; Miao Z; Xiong B
    Eur J Med Chem; 2017 Sep; 137():176-195. PubMed ID: 28586718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery, synthesis, and biological evaluation of orally active pyrrolidone derivatives as novel inhibitors of p53-MDM2 protein-protein interaction.
    Zhuang C; Miao Z; Zhu L; Dong G; Guo Z; Wang S; Zhang Y; Wu Y; Yao J; Sheng C; Zhang W
    J Med Chem; 2012 Nov; 55(22):9630-42. PubMed ID: 23046248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.
    Wang J; Wang HY; Shen Y; Liang D; Wang HY; Zhang SQ; Cao YX; Cao L
    Anticancer Drugs; 2019 Oct; 30(9):900-908. PubMed ID: 30913062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
    Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
    Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of indazole-4,7-dione derivatives as novel BRD4 inhibitors.
    Yoo M; Yoo M; Kim JE; Lee HK; Lee CO; Park CH; Jung KY
    Arch Pharm Res; 2018 Jan; 41(1):46-56. PubMed ID: 29103140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lentivirus-AIMP2-DX2 shRNA suppresses cell proliferation by regulating Akt1 signaling pathway in the lungs of AIMP2⁺/⁻ mice.
    Hwang SK; Chang SH; Minai-Tehrani A; Kim YS; Cho MH
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):165-73. PubMed ID: 23517169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
    Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
    Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIMP2 Controls Intestinal Stem Cell Compartments and Tumorigenesis by Modulating Wnt/β-Catenin Signaling.
    Yum MK; Kang JS; Lee AE; Jo YW; Seo JY; Kim HA; Kim YY; Seong J; Lee EB; Kim JH; Han JM; Kim S; Kong YY
    Cancer Res; 2016 Aug; 76(15):4559-68. PubMed ID: 27262173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.
    Zhan X; Qin W; Wang S; Zhao K; Xin Y; Wang Y; Qi Q; Mao Z
    Anticancer Agents Med Chem; 2017; 17(6):821-831. PubMed ID: 27671311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
    Cheng C; Yun F; He J; Ullah S; Yuan Q
    Eur J Med Chem; 2019 Jul; 173():185-202. PubMed ID: 31003060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity
    Son DJ; Zheng J; Jung YY; Hwang CJ; Lee HP; Woo JR; Baek SY; Ham YW; Kang MW; Shong M; Kweon GR; Song MJ; Jung JK; Han SB; Kim BY; Yoon DY; Choi BY; Hong JT
    Theranostics; 2017; 7(18):4632-4642. PubMed ID: 29158850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.